BRPI1012122A2 - métodos para manter e testar uma composição imunogênica, combinação de uma composição imunogência, e, composição imunogência. - Google Patents

métodos para manter e testar uma composição imunogênica, combinação de uma composição imunogência, e, composição imunogência.

Info

Publication number
BRPI1012122A2
BRPI1012122A2 BRPI1012122A BRPI1012122A BRPI1012122A2 BR PI1012122 A2 BRPI1012122 A2 BR PI1012122A2 BR PI1012122 A BRPI1012122 A BR PI1012122A BR PI1012122 A BRPI1012122 A BR PI1012122A BR PI1012122 A2 BRPI1012122 A2 BR PI1012122A2
Authority
BR
Brazil
Prior art keywords
composition
immunogen
testing
combining
maintaining
Prior art date
Application number
BRPI1012122A
Other languages
English (en)
Inventor
Nicolaas Visser
Theodorus Jansen
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of BRPI1012122A2 publication Critical patent/BRPI1012122A2/pt
Publication of BRPI1012122B1 publication Critical patent/BRPI1012122B1/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/135Foot- and mouth-disease virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113Multiple emulsions, e.g. oil-in-water-in-oil
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32111Aphthovirus, e.g. footandmouth disease virus
    • C12N2770/32134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
BRPI1012122-6A 2009-05-18 2010-05-18 Métodos para manter uma composição imunogênica disponível para administração a um animal e para testar uma composição imunogênica para administração a um animal BRPI1012122B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP09160451 2009-05-18
EP09160451.2 2009-05-18
US17954809P 2009-05-19 2009-05-19
US61/179548 2009-05-19
PCT/EP2010/056815 WO2010133592A1 (en) 2009-05-18 2010-05-18 A method for keeping an immunogenic composition available for administration to an animal

Publications (2)

Publication Number Publication Date
BRPI1012122A2 true BRPI1012122A2 (pt) 2016-03-29
BRPI1012122B1 BRPI1012122B1 (pt) 2021-06-15

Family

ID=41718978

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1012122-6A BRPI1012122B1 (pt) 2009-05-18 2010-05-18 Métodos para manter uma composição imunogênica disponível para administração a um animal e para testar uma composição imunogênica para administração a um animal

Country Status (8)

Country Link
US (1) US9408804B2 (pt)
EP (1) EP2432498B1 (pt)
AR (1) AR076871A1 (pt)
BR (1) BRPI1012122B1 (pt)
RU (1) RU2530582C2 (pt)
TW (1) TWI527598B (pt)
UY (1) UY32639A (pt)
WO (1) WO2010133592A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120070459A1 (en) 2010-09-22 2012-03-22 Goovaerts Daniel G E Method for keeping a foot-and-mouth disease vaccine available for emergency vaccination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU770475B2 (en) 1999-12-23 2004-02-19 Aphton Corporation A stable immunogenic composition for frozen storage
FR2814956B1 (fr) 2000-10-06 2003-01-24 Seppic Sa Nouvelle composition vaccinale, procede pour sa preparation, utilisation comme composition injectale en medecine humaine ou veterinaire et nouveau procede de conservation
US7998488B2 (en) * 2008-11-14 2011-08-16 Baxter International Inc. Vaccine formulations and uses thereof

Also Published As

Publication number Publication date
UY32639A (es) 2010-12-31
TW201105364A (en) 2011-02-16
US9408804B2 (en) 2016-08-09
EP2432498B1 (en) 2014-05-14
TWI527598B (zh) 2016-04-01
US20120087945A1 (en) 2012-04-12
RU2530582C2 (ru) 2014-10-10
AR076871A1 (es) 2011-07-13
WO2010133592A1 (en) 2010-11-25
EP2432498A1 (en) 2012-03-28
RU2011151629A (ru) 2013-06-27
BRPI1012122B1 (pt) 2021-06-15

Similar Documents

Publication Publication Date Title
BRPI1010775A2 (pt) composição, método para preparar uma composição, e, uso de uma composição.
CY1118250T1 (el) Ορισμενες τριαζολοπυραζινες, συνθεσεις αυτων και μεθοδοι για τη χρηση αυτων
BRPI1006141A2 (pt) composições de anticorpo modificado, métodos para preparar e usar as mesmas
BR112013010725A2 (pt) método, e, composição
BR112012000171A2 (pt) composição lubrificante, e, método
BRPI1011423A2 (pt) composição injetável, kit e método cosmético.
BRPI0922122A2 (pt) composições e métodos para tratamento de doença celíaca.
BRPI0912384A2 (pt) composição, e, método para preparar uma composição
BRPI0919575A2 (pt) método, e, composição
BRPI0918652A2 (pt) Composições farmacêuticas e métodos de libração relacionadas.
BRPI0918170A2 (pt) método, e, composição endurecível
BR112012003092A2 (pt) composições e métodos para implantação de tecido adiposo processado e produtos de tecido adiposo processados.
BR112012002608A2 (pt) composição lubrificante, e, método para melhorar o desempenho de uma composição lubrificante.
BRPI1008021A2 (pt) Método para fabricação de 2,6-dioxabiciclo-(3.3.0)-octano-4,8-diona
BR112012000623A2 (pt) composição de emulsão estabilizada, método, e, método para preparar uma composição de emulsão estabilizada
BRPI0917714A2 (pt) método para preparar uma microesfera de liberação prolongada, e, microesfera de liberação prolongada
BRPI0823277A2 (pt) Composição, e , método
BRPI1014035A2 (pt) método para contracepção.
BRPI0923801A2 (pt) Métodos para produzir um éster, e para produzir amidas.
BRPI0912263A2 (pt) composição de vacina, e, método para imunizar uma cobaia animal contra coccidiose
BRPI1011012A2 (pt) composição de lubrificante, e, método
BRPI0911252A2 (pt) método, extrato, e, composição.
BRPI1011639A2 (pt) composição anticongelante, e, método para aumentar a estabilidade térmica de uma composição anticongelante
DK2402032T3 (da) Immunogen sammensætning
BRPI0916936A2 (pt) composições faramacêuticas e métodos para produzir baixas concentrações de impureza da mesmas.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/05/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF